A new study from Georgia State University examined the mechanisms by which resveratrol was able to work against Haemophilus influenzae, a major respiratory pathogen. The findings may be of use in developing non-antibiotic treatments for bacterial respiratory infections, and also for COPD and asthma therapies.
“The reason we are talking about vaccinations is that they are some of the simplest interventions we can provide our patients to reduce heart failure (HF) hospitalizations and HF exacerbations,” says Dr. Orly Vardeny, PharmD.
While the influenza vaccine has endured its fair share of controversy, new research shed light on one of the flu shot’s added benefits: diabetes patients who get the vaccine may not suffer as many cardiovascular or respiratory problems.
Researchers have described a novel strategy that could augment the current process for forecasting the naturally occurring mutations that help seasonal flu virus dodge the vaccine with a more precise approach.